Biomerica, Inc.
BMRA
$2.27
-$0.08-3.21%
NASDAQ
| 05/31/2026 | 02/28/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -11.35% | -18.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.35% | -18.43% | |||
| Cost of Revenue | -8.24% | -11.04% | |||
| Gross Profit | -61.36% | -186.27% | |||
| SG&A Expenses | 16.82% | -12.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.38% | -11.54% | |||
| Operating Income | -18.10% | 5.46% | |||
| Income Before Tax | 12.65% | 0.84% | |||
| Income Tax Expenses | -25.00% | 60.00% | |||
| Earnings from Continuing Operations | 12.73% | 0.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.73% | 0.61% | |||
| EBIT | -18.10% | 5.46% | |||
| EBITDA | -18.62% | 5.54% | |||
| EPS Basic | 15.35% | 3.99% | |||
| Normalized Basic EPS | -91.47% | 4.21% | |||
| EPS Diluted | 14.66% | 3.06% | |||
| Normalized Diluted EPS | -91.47% | 4.21% | |||
| Average Basic Shares Outstanding | 3.10% | 3.51% | |||
| Average Diluted Shares Outstanding | 3.10% | 3.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||